Human recombinant DNase in cystic fibrosis.
作者信息
Thomson A H
机构信息
Department of Paediatrics, John Radcliffe Hospital, Headington, Oxford.
出版信息
J R Soc Med. 1995;88 Suppl 25(Suppl 25):24-9.
Abstract
摘要
相似文献
1
Human recombinant DNase in cystic fibrosis.囊性纤维化中的人重组脱氧核糖核酸酶
J R Soc Med. 1995;88 Suppl 25(Suppl 25):24-9.
2
New treatment for cystic fibrosis.
Am Pharm. 1994 Feb;NS34(2):16-8.
3
Comment: cost of rhDNase in cystic fibrosis.评论：囊性纤维化中重组人脱氧核糖核酸酶的成本
Ann Pharmacother. 1995 Oct;29(10):1050-1. doi: 10.1177/106002809502901024.
4
Nebulised bronchodilators, antibiotics and rhDNase for children with cystic fibrosis.用于囊性纤维化患儿的雾化支气管扩张剂、抗生素和重组人脱氧核糖核酸酶
Thorax. 1997 Apr;52 Suppl 2(Suppl 2):S89-91. doi: 10.1136/thx.52.2008.s89.
5
Consensus conference: practical applications of Pulmozyme. September 22, 1993.
Pediatr Pulmonol. 1994 Jun;17(6):404-8. doi: 10.1002/ppul.1950170613.
6
Nebulised bronchodilators, corticosteroids, and rhDNase in adult patients with cystic fibrosis.雾化支气管扩张剂、皮质类固醇和重组人脱氧核糖核酸酶用于成年囊性纤维化患者的治疗
Thorax. 1997 Apr;52 Suppl 2(Suppl 2):S64-8. doi: 10.1136/thx.52.2008.s64.
7
Early treatment with dornase alfa in cystic fibrosis: what are the issues?囊性纤维化患者早期使用重组人脱氧核糖核酸酶治疗：存在哪些问题？
Pediatr Pulmonol. 1998 Feb;25(2):79-82. doi: 10.1002/(sici)1099-0496(199802)25:2<79::aid-ppul1>3.0.co;2-i.
8
[Cystic fibrosis. Current indications for nebulized treatments: antibiotics and DNase].[囊性纤维化。雾化治疗的当前适应证：抗生素和脱氧核糖核酸酶]
Rev Mal Respir. 1999 Jan;16 Suppl 3:S131-2.
9
Jet nebulising systems for recombinant human DNase I.用于重组人脱氧核糖核酸酶I的喷射雾化系统。
Arch Dis Child. 1994 Dec;71(6):558-9. doi: 10.1136/adc.71.6.558-a.
10
Dornase-alfa (DNase, Pulmozyme) for cystic fibrosis.用于治疗囊性纤维化的重组人脱氧核糖核酸酶（DNase，普米克令舒）
Intensive Crit Care Nurs. 1998 Apr;14(2):101-2. doi: 10.1016/s0964-3397(98)80268-1.
引用本文的文献
1
NETosis-based prognostic model reveals immune modulation in clear cell renal cell carcinoma using single-cell and bulk RNA sequencing.基于NETosis的预后模型通过单细胞和批量RNA测序揭示透明细胞肾细胞癌中的免疫调节。
Sci Rep. 2025 Jul 25;15(1):27156. doi: 10.1038/s41598-025-11095-7.
2
AAV-mouse DNase I sustains long-term DNase I expression in vivo and suppresses breast cancer metastasis.腺相关病毒介导的小鼠脱氧核糖核酸酶I在体内维持长期脱氧核糖核酸酶I表达并抑制乳腺癌转移。
FASEB Bioadv. 2024 Aug 30;6(10):454-466. doi: 10.1096/fba.2024-00114. eCollection 2024 Oct.
3
Neutrophil Extracellular Trap Scores Predict 90-Day Mortality in Hepatitis B-Related Acute-on-Chronic Liver Failure.中性粒细胞胞外诱捕网评分可预测乙型肝炎相关慢加急性肝衰竭患者90天死亡率。
Biomedicines. 2024 Sep 9;12(9):2048. doi: 10.3390/biomedicines12092048.
4
Neutrophil extracellular traps induce intrahepatic thrombotic tendency and liver damage in cholestatic liver disease.中性粒细胞胞外诱捕网可诱发胆汁淤积性肝病的肝内血栓形成倾向和肝损伤。
Hepatol Commun. 2024 Aug 5;8(8). doi: 10.1097/HC9.0000000000000513. eCollection 2024 Aug 1.
5
Neutrophil extracellular traps primed intercellular communication in cancer progression as a promising therapeutic target.中性粒细胞胞外陷阱在癌症进展中引发细胞间通讯，是一个有前景的治疗靶点。
Biomark Res. 2023 Mar 2;11(1):24. doi: 10.1186/s40364-023-00463-y.
6
Neutrophil extracellular traps in the pathology of cancer and other inflammatory diseases.中性粒细胞胞外陷阱在癌症和其他炎症性疾病中的作用。
Physiol Rev. 2023 Jan 1;103(1):277-312. doi: 10.1152/physrev.00062.2021. Epub 2022 Aug 11.
7
Neutrophil extracellular traps promote cancer-associated inflammation and myocardial stress.中性粒细胞胞外诱捕网促进癌相关炎症和心肌应激。
Oncoimmunology. 2022 Mar 14;11(1):2049487. doi: 10.1080/2162402X.2022.2049487. eCollection 2022.
8
PAD4-dependent NETs generation are indispensable for intestinal clearance of Citrobacter rodentium.PAD4 依赖性 NETs 的产生对于柠檬酸杆菌的肠道清除是不可或缺的。
Mucosal Immunol. 2019 May;12(3):761-771. doi: 10.1038/s41385-019-0139-3. Epub 2019 Feb 1.
9
Neutrophils and neutrophil extracellular traps in the liver and gastrointestinal system.中性粒细胞和中性粒细胞胞外诱捕网在肝脏和胃肠道系统中的作用。
Nat Rev Gastroenterol Hepatol. 2018 Apr;15(4):206-221. doi: 10.1038/nrgastro.2017.183. Epub 2018 Jan 31.
10
Pharmacological targeting of peptidylarginine deiminase 4 prevents cancer-associated kidney injury in mice.对肽基精氨酸脱亚氨酶4进行药物靶向治疗可预防小鼠的癌症相关肾损伤。
Oncoimmunology. 2017 Apr 20;6(8):e1320009. doi: 10.1080/2162402X.2017.1320009. eCollection 2017.
本文引用的文献
1
Liquefaction of viscous purulent exudates by deoxyribonuclease.脱氧核糖核酸酶对粘性脓性渗出物的液化作用。
Lancet. 1950 Dec 9;2(6641):739-42. doi: 10.1016/s0140-6736(50)91676-x.
2
Composition of tracheobronchial secretions in cystic fibrosis of the pancreas and bronchiectasis.胰腺囊性纤维化和支气管扩张时气管支气管分泌物的成分
Pediatrics. 1959 Nov;24:739-45.
3
4
Efficacy and safety of short-term administration of aerosolised recombinant human DNase I in adults with stable stage cystic fibrosis.雾化吸入重组人脱氧核糖核酸酶I短期治疗稳定期成人囊性纤维化的疗效和安全性。
Lancet. 1993 Jul 24;342(8865):199-202. doi: 10.1016/0140-6736(93)92297-7.
5
Effect of aerosolized recombinant human DNase on exacerbations of respiratory symptoms and on pulmonary function in patients with cystic fibrosis. The Pulmozyme Study Group.雾化重组人脱氧核糖核酸酶对囊性纤维化患者呼吸道症状加重及肺功能的影响。Pulmozyme研究组。
N Engl J Med. 1994 Sep 8;331(10):637-42. doi: 10.1056/NEJM199409083311003.
6
Within-subject variability and per cent change for significance of spirometry in normal subjects and in patients with cystic fibrosis.
Am Rev Respir Dis. 1980 Dec;122(6):859-66. doi: 10.1164/arrd.1980.122.6.859.
7
Dornase aerosol effect on sputum viscosity in cases of cystic fibrosis.多纳酶气雾剂对囊性纤维化患者痰液黏稠度的影响。
JAMA. 1968 Jul 29;205(5):312-3.
8
Bronchospasm after inhalation of pancreatic dornase.
Am Rev Respir Dis. 1968 Oct;98(4):697-8. doi: 10.1164/arrd.1968.98.4.697.
9
Variability of pulmonary function tests in cystic fibrosis.囊性纤维化患者肺功能测试的变异性
Pediatr Pulmonol. 1990;8(1):16-22. doi: 10.1002/ppul.1950080107.
10
Recombinant human DNase I reduces the viscosity of cystic fibrosis sputum.重组人脱氧核糖核酸酶I降低囊性纤维化痰液的黏稠度。
Proc Natl Acad Sci U S A. 1990 Dec;87(23):9188-92. doi: 10.1073/pnas.87.23.9188.
Zotero 插件